Patterns of care in prostate cancer (PCa) have changed tremendously in the past 20 years, altering the way patients with this tumor present and how they are evaluated before and after diagnosis. With the use of new and combined treatments, the frequency and variety of complications have differed from those previously reported. Advances have been made in PCa imaging, biopsy methodology, in understanding causative factors and disease, in treatment-related quality of life, and in predicting the behavior of individual tumors using risk strata. Despite these advances, no consensus has emerged regarding the optimal treatment for the most common patient with PCa.
There is a need for oncologists, urologists, and nurses to understand the rationale behind targeted therapy for the treatment of advanced PCa, and how trial entry could improve the efficacy of drugs and decrease the toxicity. This activity seeks to educate urologists and other healthcare professionals about the latest advances in the prevention, screening, and treatment of PCa. The International Prostate Cancer Update (IPCU) educational planning committee has identified the following educational gaps between recent research in PCa and its integration into professional practice at the international, national, and community levels:
Payment with credit card can be made via this website. If paying by check, make checks payable to Carden Jennings Publishing Co., Ltd. and addressed to:
Carden Jennings Publishing Co., Ltd.
375 Greenbrier Drive, Suite 100
Charlottesville, VA 22901
You are invited to submit an abstract reflecting your latest findings in the fields of prostate cancer management and prevention. Authors of accepted submissions will be invited to display a poster at the meeting, as well as give a brief oral presentation.
Please submit an abstract of 500 words or less (single-spaced, 10-point size); include a title for the abstract
Spell out complete names of all authors
List the institution, city, state, country, and e-mail address of the presenting author
E-mail the document to email@example.com
The deadline for submitting abstracts for the 25th International Prostate Cancer Update is December 31, 2014.